Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8+ T cell activation to eradicate hepatocellular carcinoma
Chun‐Chia Cheng, Ai‐Sheng Ho, Cheng‐Liang Peng, Jungshan Chang, Zong‐Lin Sie, Chih‐Liang Wang, Yili Chen, Cheng‐Yi Chen
Topics & Concepts
SorafenibRadioresistanceCancer researchCD8Cytotoxic T cellGranzyme BHepatocellular carcinomaPerforinBiologyImmunologyImmune systemCell cultureIn vitroGeneticsBiochemistryCancer Immunotherapy and BiomarkersImmune Cell Function and InteractionCytokine Signaling Pathways and Interactions